Counter-cyclical layout of high-performance fluorinated New Materials, Zhejiang Juhua invested 4.2 billion yuan to increase its stake in Gansu Juhua | Quick Announcement
① After the completion of the high-performance fluorinated new materials project, the average annual sales revenue will be 8.211 billion yuan, with an average annual net income of 1.068 billion yuan; ② Zhejiang Juhua stated that the high-performance fluorinated new materials project is an urgent need for Zhejiang Juhua to maintain its leading position in fluorinated refrigerants and fluoropolymers; ③ In recent years, market competition in fluoropolymers has been fierce, being at the bottom of the industry cycle, and major domestic fluorochemical competitors have been approaching resource areas.
At the time of divesting from photovoltaics, China Suntien Green Energy Corporation's Listed in Hong Kong saw a capital increase from Great Wall Life Insurance.
On February 14, the Hong Kong Stock Exchange revealed that China Suntien Green Energy Corporation's H shares were increased in shareholding by Great Wall Life Insurance on February 12, involving an investment of 9.344 million Hong Kong dollars; after the increase in shareholding, ...
The 2024 Net income is expected to turn from loss to profit. Yueyang Forest & Paper "intensively" acquires old assets to enhance performance | Interpretations
① Yueyang Forest & Paper expects to turn from a loss to a profit in net income for 2024, boosted by the performance of Juntao Technology, which was acquired in late December last year; ② Affected by weak overall market demand, the company's paper product sales volume is expected to decline year-on-year in 2024, and the sales prices of paper products have decreased compared to the same period last year.
The recovery of Semiconductors could not withstand the erosion of costs, Hunan Kaimeite Gases' losses widened last year | Interpretations
① Hunan Kaimeite Gases expects to incur a net income loss of 43.8 million yuan to 54 million yuan in 2024; ② The company stated that the main reasons for the decline in performance are: first, the prices of rare gas related products decreased; second, the termination of the restrictive stocks incentive plan implemented in 2022, which will be included as corresponding costs and expenses in 2024.
The rebalancing pace has accelerated! Swiss Re Life invested 29.09 million Hong Kong dollars to increase its shareholding in CHINA LONGYUAN H shares. This year, insurance capital has sparked a new wave of "stake-building."
① This time, Ruizhong Life has increased its stake in CHINA LONGYUAN H shares as part of equity investment management; ② Asset returns are under pressure, and within the year, insurance funds have initiated a new round of "stake acquisition boom"; ③ As of December 25, at least 8 insurance institutions have increased their stakes in 20 listed companies this year.
RuiZhong Life increased its Shareholding in CHINA LONGYUAN to 1%. Insurance capital is Bullish on undervalued, high-dividend Assets.
① Increase the shareholding of CHINA LONGYUAN Listed in Hong Kong through self-owned funds via centralized bidding in the secondary market; ② After this shareholding increase is completed, Ruizhong Life will Hold 0.502 billion shares of CHINA LONGYUAN Listed in Hong Kong; ③ The funds for this shareholding increase come from self-owned funds.